COVID-19 Among Patients With Inflammatory Rheumatic Diseases

BACKGROUND: The course of novel coronavirus disease 2019 (COVID-19) has been of special concern in patients with inflammatory rheumatic diseases (IRDs) due to the immune dysregulation that may be associated with these diseases and the medications used for IRDs, that may affect innate immune response...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Immunol
Asıl Yazarlar: Esatoglu, Sinem Nihal, Tascilar, Koray, Babaoğlu, Hakan, Bes, Cemal, Yurttas, Berna, Akar, Servet, Pehlivan, Ozlem, Akleylek, Cansu, Tecer, Duygu, Seyahi, Emire, Yuce-Inel, Tuba, Alpay-Kanitez, Nilufer, Bodakci, Erdal, Tekgoz, Emre, Colak, Seda, Bolek, Ertugrul Cagri, Koca, Suleyman Serdar, Kalyoncu, Umut, Icacan, Ozan Cemal, Ugurlu, Serdal, Oz, Hande Ece, Hamuryudan, Vedat, Hatemi, Gulen
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2021
Konular:
Immunology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8086428/
https://ncbi.nlm.nih.gov/pubmed/33936073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.651715
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller